Press Release: Open PHACTS Foundation announces first three members: GSK, Janssen and Roche

(PDFCambridge, UK – The not-for-profit Open PHACTS Foundation announced its first three members today – GlaxoSmithKline, Janssen and Roche – who will steer the future of the successor organisation to the Innovative Medicines Initiative (IMI)- funded Open PHACTS project.

The commitment by these global pharmaceutical industry members signifies a major step in ensuring the sustainability of infrastructure developed during the Open PHACTS project.